Non-valvular Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Non-valvular Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Amplatzer Amulet China Post Market Study (PMS)
Post-market study results for Amplatzer Amulet in China in patients with non-valvular atrial fibrillation have been posted after termination…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination [NA]
A pivotal IDE study on laminar left atrial appendage elimination for non-valvular atrial fibrillation is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation [Phase 4]
This Phase 4 study evaluates the population pharmacokinetics of edoxaban in Chinese patients with non-valvular atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Amplatzer Amulet China Post Market Study (PMS)
A post-market study of the Amplatzer Amulet in China sponsored by Abbott Medical Devices has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Watchman FLX Pro CT Pilot Study [NA]
A completed pilot clinical trial evaluating the Watchman FLX Pro CT device for non-valvular atrial fibrillation with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: WATCHMAN FLX™ CT Study [NA]
This clinical trial update reports the completion of the WATCHMAN FLX CT Study evaluating left atrial appendage closure to reduce stroke and…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
This clinical trial update reports the clinical and economic outcomes of oral anticoagulants in patients with non-valvular atrial fibrillati…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update showing enrollment for a head-to-head comparison of apixaban versus rivaroxaban in non-valvular atrial fibrill…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
A real-world study evaluating edoxaban use in patients with non-valvular atrial fibrillation in China has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
This completed study assessed the safety and effectiveness of rivaroxaban (Xarelto) for prevention of stroke and systemic embolism in Indian…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis
A completed clinical trial compares safety and effectiveness of warfarin versus apixaban in patients with end-stage kidney disease on dialys…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment
A completed observational trial update from Bayer describing an Italian study to quantify how many non-valvular atrial fibrillation patients…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: The Conformal Prague Study [NA]
Results from the Conformal Prague Study, sponsored by Conformal Medical, have been posted for non-valvular atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong
Clinical trial update indicating the WATCHMAN FLX left atrial appendage closure device was evaluated for safety and effectiveness in Hong Ko…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
A Bayer-sponsored real-world study evaluating the safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibri…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban [NA]
A terminated clinical trial evaluating changes in coagulation activity in patients with non-valvular atrial fibrillation being treated with …
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding
A completed clinical trial comparing apixaban to warfarin in patients with non-valvular atrial fibrillation who have a higher risk of bleedi…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
A Pfizer-sponsored analysis evaluates safety and effectiveness of apixaban versus warfarin in very elderly patients with non-valvular atrial…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: WAVECREST Post Market Clinical Follow-Up (PMCF) Study [NA]
Post-market clinical follow-up study for WAVECREST in non-valvular atrial fibrillation has terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation
A clinical trial comparing apixaban to warfarin for secondary prevention in non-valvular atrial fibrillation has completed; results were pos…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) [Phase 4]
Phase 4 trial update evaluating optimal antithrombotic therapy for acute coronary syndrome patients with non-valvular atrial fibrillation wh…
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: AMPLATZER™ Cardiac Plug Observational Post-Approval Study
Post-approval observational study of the AMPLATZER Cardiac Plug in non-valvular atrial fibrillation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation [Phase 4]
Phase 4 trial update assessing how anticoagulation therapy affects cognitive decline and dementia in patients with non-valvular atrial fibri…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON) [Phase 4]
Phase 4 clinical trial update evaluating oral anticoagulants in diabetic and non-diabetic patients with non-valvular atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
Clinical trial update on the safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation has completed…